• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组溶瘤腺病毒 H101 联合 siBCL2 对葡萄膜黑色素瘤细胞系的细胞毒性作用。

Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines.

机构信息

Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, PR China.

出版信息

Br J Ophthalmol. 2012 Oct;96(10):1331-8. doi: 10.1136/bjophthalmol-2011-301470. Epub 2012 Jul 27.

DOI:10.1136/bjophthalmol-2011-301470
PMID:22843987
Abstract

BACKGROUND

Deregulation of Bcl2 pathway is implicated in the pathogenesis of uveal melanoma (UM). Oncolytic adenovirus H101 is the world's first oncolytic viral therapy for cancer approved for clinical use. We aimed to explore a potential synergy of downregulating Bcl2 pathway using a small interfering RNA (siBCL2) combined with H101 therapy on UM cell lines.

METHODS

The sensitivity to adenovirus infection was analysed by flow cytometry. PCR, real-time-PCR and western blot were used to detect Bcl2, p53, Bax and fibre expression. Appropriate multiplicity of H101 infection and cell survival rate were measured by a cell counting kit-8 assay. UM cells were stained with Annexin-V and propidium iodide for apoptosis assay and cell cycle distribution.

RESULTS

VUP cells (without elevation of Bcl2) exhibited greater sensitivity to adenovirus infection than OM431 cells (Bcl2 elevated cell line). Bcl2 expression was markedly reduced by siBCL2 or siBCL2 plus H101. Combined treatment with siBCL2 and H101 produced substantial growth inhibition of OM431 cells by enhancing apoptosis and cell cycle arrest through Bax-p53-induced apoptotic pathway.

CONCLUSIONS

SiBCL2 and H101 exhibited synergistic cytotoxic effect in Bcl2 elevated UM cell lines and could potentially serve as a novel targeted molecular therapy for UM.

摘要

背景

Bcl2 通路的失调与葡萄膜黑色素瘤(UM)的发病机制有关。溶瘤腺病毒 H101 是世界上第一个获准临床使用的溶瘤病毒癌症治疗药物。我们旨在探索使用小干扰 RNA(siBCL2)联合 H101 治疗下调 Bcl2 通路的潜在协同作用,用于 UM 细胞系。

方法

通过流式细胞术分析对腺病毒感染的敏感性。PCR、实时 PCR 和 Western blot 用于检测 Bcl2、p53、Bax 和纤维表达。通过细胞计数试剂盒-8 测定适当的 H101 感染倍数和细胞存活率。用 Annexin-V 和碘化丙啶对 UM 细胞进行染色,进行凋亡检测和细胞周期分布。

结果

VUP 细胞(Bcl2 未升高)对腺病毒感染的敏感性高于 OM431 细胞(Bcl2 升高细胞系)。siBCL2 或 siBCL2 加 H101 显著降低了 Bcl2 的表达。siBCL2 和 H101 的联合治疗通过 Bax-p53 诱导的凋亡途径增强凋亡和细胞周期停滞,对 OM431 细胞产生了显著的生长抑制作用。

结论

siBCL2 和 H101 在 Bcl2 升高的 UM 细胞系中表现出协同细胞毒性作用,可能作为 UM 的一种新型靶向分子治疗方法。

相似文献

1
Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines.重组溶瘤腺病毒 H101 联合 siBCL2 对葡萄膜黑色素瘤细胞系的细胞毒性作用。
Br J Ophthalmol. 2012 Oct;96(10):1331-8. doi: 10.1136/bjophthalmol-2011-301470. Epub 2012 Jul 27.
2
The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability.溶瘤病毒 H101 联合 GNAQ siRNA 介导的基因沉默降低葡萄膜黑色素瘤细胞活力。
J Cell Biochem. 2019 Apr;120(4):5766-5776. doi: 10.1002/jcb.27863. Epub 2018 Oct 15.
3
Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.用条件复制溶瘤腺病毒 H101 在体外和体内抑制视网膜母细胞瘤。
Invest Ophthalmol Vis Sci. 2010 May;51(5):2626-35. doi: 10.1167/iovs.09-3516. Epub 2009 Dec 10.
4
Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors.通过同时靶向肿瘤中的两个基因缺陷提高治疗效果。
Mol Ther. 2009 Jan;17(1):57-64. doi: 10.1038/mt.2008.236. Epub 2008 Nov 18.
5
Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.溶瘤腺病毒与达卡巴嗪联合通过细胞周期阻滞减弱对葡萄膜黑色素瘤细胞的抗肿瘤能力。
Cancer Biol Ther. 2012 Jan 15;13(2):77-84. doi: 10.4161/cbt.13.2.18436.
6
The antitumor effects of oncolytic adenovirus H101 against lung cancer.溶瘤腺病毒H101对肺癌的抗肿瘤作用。
Int J Oncol. 2015 Aug;47(2):555-62. doi: 10.3892/ijo.2015.3045. Epub 2015 Jun 11.
7
Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.通过靶向纠正脉络膜肿瘤中 Notch1 诱导的异常来实现治疗效果。
PLoS One. 2012;7(8):e44301. doi: 10.1371/journal.pone.0044301. Epub 2012 Aug 28.
8
[Effect of CEA gene regulation on the anti-tumor activity of oncolytic adenovirus H101 to esophageal carcinoma].
Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):822-6.
9
Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.条件复制型腺病毒介导白细胞介素-24 联合达卡巴嗪增强对黑色素瘤细胞的抗肿瘤活性,通过诱导细胞凋亡。
Cancer Lett. 2010 Aug 28;294(2):220-8. doi: 10.1016/j.canlet.2010.02.003. Epub 2010 Feb 26.
10
An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.携带 IL-24 的溶瘤腺病毒 ZD55 联合 ADM 或 DDP 对肺癌具有协同抗肿瘤作用。
Acta Oncol. 2010;49(1):91-9. doi: 10.3109/02841860903246557.

引用本文的文献

1
The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis.溶瘤病毒治疗中晚期实体瘤的疗效与安全性:一项系统评价和荟萃分析。
Transl Cancer Res. 2021 Oct;10(10):4290-4302. doi: 10.21037/tcr-21-905.
2
Oncolytic Virotherapy: From Bench to Bedside.溶瘤病毒疗法:从实验台到临床应用
Front Cell Dev Biol. 2021 Nov 26;9:790150. doi: 10.3389/fcell.2021.790150. eCollection 2021.
3
Antitumor Efficacy of Oncolytic Herpes Virus Type 1 Armed with GM-CSF in Murine Uveal Melanoma Xenografts.
携带GM-CSF的1型溶瘤性疱疹病毒在小鼠葡萄膜黑色素瘤异种移植瘤中的抗肿瘤疗效
Cancer Manag Res. 2020 Nov 18;12:11803-11812. doi: 10.2147/CMAR.S274605. eCollection 2020.
4
ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report.溶瘤病毒ECHO-7 Rigvir®用于I期葡萄膜黑色素瘤辅助治疗的回顾性病例报告
Am J Ophthalmol Case Rep. 2020 Jan 31;17:100615. doi: 10.1016/j.ajoc.2020.100615. eCollection 2020 Mar.
5
The biology of uveal melanoma.葡萄膜黑色素瘤的生物学
Cancer Metastasis Rev. 2017 Mar;36(1):109-140. doi: 10.1007/s10555-017-9663-3.
6
Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.抑制刺猬信号通路对葡萄膜黑色素瘤细胞生长和迁移的影响。
Cancer Biol Ther. 2014 May;15(5):544-59. doi: 10.4161/cbt.28157. Epub 2014 Mar 11.
7
The role of Bax and Bcl-2 in gemcitabine-mediated cytotoxicity in uveal melanoma cells.Bax和Bcl-2在吉西他滨介导的葡萄膜黑色素瘤细胞毒性中的作用。
Tumour Biol. 2014 Feb;35(2):1169-75. doi: 10.1007/s13277-013-1156-6. Epub 2013 Sep 7.
8
Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells.由微小RNA反应元件介导的肿瘤靶向性TRAIL表达抑制了葡萄膜黑色素瘤细胞的生长。
Mol Oncol. 2013 Dec;7(6):1043-55. doi: 10.1016/j.molonc.2013.08.003. Epub 2013 Aug 16.
9
Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment.通过纳入对黑色素瘤微环境有响应的动机,来改善基质靶向的 CRAd 的治疗效果。
J Invest Dermatol. 2013 Nov;133(11):2576-2584. doi: 10.1038/jid.2013.191. Epub 2013 Apr 19.
10
Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.通过靶向纠正脉络膜肿瘤中 Notch1 诱导的异常来实现治疗效果。
PLoS One. 2012;7(8):e44301. doi: 10.1371/journal.pone.0044301. Epub 2012 Aug 28.